Cowin Venture is an angel and early-stage investor in TMT and Healthcare.
Business Model:
Revenue: $0
Employees: 0-0
Address: No 38 East Third Ring Road
City: Beijing
State: beijing municipality
Zip: 100010
Country: CN
Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
3/2022 | Celsius Therapeutics | Series B | 0 |
9/2021 | FORQALY | Series B | - |
11/2017 | TETRA ELC | Series A | 1.5M |
1/2018 | Sinovation Medical | Series A | 0 |
12/2016 | TETRA ELC | Angel Round | 1.5M |
9/2022 | Mesai Biotech | Series A | - |
1/2016 | Yidu Yuanqi | Angel Round | 459.2k |
7/2018 | Neighboring good doctors | Series A | - |
5/2022 | Supervision Technology | Seed Round | 0 |
2/2021 | Immorna | Series A | 15.5M |
12/2010 | Jia.com | Series A | 41.5M |
4/2020 | Tuxing Keji | Seed Round | 1.4M |
12/2022 | Sinovation Medical | Series D | 43.1M |
6/2018 | Aidong Super AI | Angel Round | 458.7k |
10/2016 | Linked-F | Series A | 3.3M |
12/2015 | Leads Biolabs | Angel Round | - |
10/2019 | Taimei Technology | Series E | 211.8M |
10/2022 | Xindi Digital Engineering System | Venture Round | 96.8M |
10/2019 | GeneCast Biotechnology | Series D | 42.5M |
9/2018 | Aidong Super AI | Series A | 1.5M |
12/2013 | Howsome | Series A | 1.6M |
9/2017 | Paragon Genomics, Inc. | Series A | 8M |
3/2022 | Arima Genomics | Series B | 0 |
6/2014 | PegBio | Series B | - |
5/2018 | Neucyte, Inc. | Series A | 6.7M |
8/2022 | Jade Bird Display | Series A | - |
10/2015 | Lightning Expense | Series A | 1.6M |
4/2020 | Luxin DB Software | Angel Round | - |
6/2014 | Taimei Technology | Angel Round | - |
7/2018 | NeighBor Doc | Series A | 3M |
7/2020 | Rapid Novor | Series A | 5M |
3/2021 | Aucta Pharmaceuticals China | Series A | - |
10/2021 | Raypaitech | Series A | 1.5M |
3/2012 | DeeSha | Angel Round | 473.9k |
5/2017 | AMT | Series E | 7.2M |
1/2022 | Amberstone Biosciences | Series A | 0 |
2/2020 | Arima Genomics | Series A | - |
4/2020 | BennuBio | Series B | 0 |
1/2017 | Taimei Technology | Series C | 14.5M |
11/2016 | NeighBor Doc | Seed Round | 1.5M |
8/2018 | Luxin Technology (Lu-Semi) | Series A | - |
2/2021 | Bioelectronica | Series A | - |
7/2017 | Leads Biolabs | Series A | - |
2/2018 | GeneCast Biotechnology | Series C | 33M |
9/2020 | Taimei Technology | Venture Round | 0 |
6/2022 | Degron Therapeutics | Series A | 0 |
12/2021 | Amador Bioscience | Series B | 60M |
1/2020 | Fluent BioSciences | Series A | 0 |
2/2022 | Ucello Therapeutics | Series A | 0 |
1/2018 | Zhong Fangdingqi | Angel Round | 473.4k |
3/2021 | Neuracle | Series B | - |
6/2016 | Taimei Technology | Series B | - |
8/2021 | Neuexcell Therapeutics | Pre-Series A | 10M |
9/2021 | Amador Bioscience | Series B | - |
4/2018 | Taimei Technology | Series D | 47.8M |
7/2020 | Thrive Earlier Detection | Series B | 0 |
12/2017 | Meijun Electronic | Angel Round | - |
7/2021 | Hongyun Biotech | Series B | 15.4M |
1/2019 | Taimei Technology | Series E | 80M |
7/2016 | Synbio Technologies | Series B | 3M |
8/2015 | Fangcun Doctor | Angel Round | 468.2k |
5/2019 | Thrive Earlier Detection | Series A | 110M |
6/2022 | Degron Therapeutics | Series A | 0 |
5/2022 | Supervision Technology | Seed Round | 0 |
3/2022 | Celsius Therapeutics | Series B | 0 |
3/2022 | Arima Genomics | Series B | 0 |
2/2022 | Ucello Therapeutics | Series A | 0 |
1/2022 | Amberstone Biosciences | Series A | 0 |
12/2021 | Amador Bioscience | Series B | 0 |
10/2021 | Raypaitech | Series A | 0 |
9/2021 | FORQALY | Series B | - |
9/2021 | Amador Bioscience | Series B | - |
Name | Price |
---|
Name | Size | Announced Date |
---|